glp-1 and substance use disorder Receptor Agonists Research to Treat Overeating and Disorders What to know about how

[DOI] [PubMed] [Google Scholar] [53].Rosenstock J, Raccah D, Koranyi L, Maffei L, Boka G, Miossec P, Gerich JE, Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X), Diabetes care, 36 (2013) 29452951

Instead, the startup set out to help patients taking GLP-1s which began as a class of diabetes drugs make changes to their diet and exercise

Constipation in DM are associated with both poor glycemic control and diabetic complications: current status and future directions

If you lose 10% or more of your body weight while taking levothyroxine at a dose calibrated for your higher weight, you may become relatively over-medicated